# An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy

> **NCT04794491** · PHASE4 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 62 (actual)

## Conditions studied

- Narcolepsy

## Interventions

- **DRUG:** JZP-258

## Key facts

- **NCT ID:** NCT04794491
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-22
- **Primary completion:** 2022-11-15
- **Final completion:** 2022-11-15
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2024-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04794491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04794491, "An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04794491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*